Yoshiyuki Morishima
6PUBLICATIONS
18CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Oct 19, 2022
Home Blood Pressure Can Predict the Risk for Stroke/Bleeding Events in Elderly Patients With Nonvalvular Atrial Fibrillation From the ANAFIE Registry.Kazuomi Kario, Naoyuki Hasebe, Ken Okumura
|Apr 20, 2022
Impact of Previous Stroke on Clinical Outcome in Elderly Patients With Nonvalvular Atrial Fibrillation: ANAFIE Registry.Takeshi Yoshimoto, Kazunori Toyoda, Masafumi Ihara
|Feb 03, 2021
Edoxaban, a direct oral factor Xa inhibitor, ameliorates coagulation, microvascular thrombus formation, and acute liver injury in a lipopolysaccharide-induced coagulopathy model in rats.Yoshiyuki Morishima, Tomoko Shibutani, Kengo Noguchi
|Aug 10, 2019
Combined effect of a direct oral anticoagulant edoxaban and an inhibitor of activated thrombin-activatable fibrinolysis inhibitor on clot lysis.Yoshiyuki Morishima, Chikako Kamisato, Yuko Honda
|Apr 12, 2019
A direct oral anticoagulant edoxaban accelerated fibrinolysis via enhancement of plasmin generation in human plasma: dependent on thrombin-activatable fibrinolysis inhibitor.Yoshiyuki Morishima, Yuko Honda
|Apr 29, 2018
A direct oral factor Xa inhibitor edoxaban ameliorates neointimal hyperplasia following vascular injury and thrombosis in apolipoprotein E-deficient mice.Yoshiyuki Morishima, Yuko Honda
Pageof 1
Frequent Collaborators
2 joint publications
Kazunori Toyoda
2 joint publications
Wataru Shimizu
2 joint publications
Hiroshi Inoue
2 joint publications
Takeshi Yamashita
2 joint publications
Shinya Suzuki
2 joint publications
Masaharu Akao
2 joint publications
Hirotsugu Atarashi
2 joint publications
Takanori Ikeda
2 joint publications
Ken Okumura
2 joint publications
Yukihiro Koretsune
